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Assessment of Testicular Toxicity in
Laboratory Animals
by Ralph Heywood* and Ronald W. James*
The currently available methods ofassessing testicular toxicity and fertility are discussed. Compounds
inducing testicular atrophy mainly affect the seminiferous epithelium, with progressive loss of sper-
matozoa, spermatids, spermatocytes, and spermatogonia. Quantitative histometric analysis of sper-
matogenesis, together with hormone assays, could be used to advantage in defining the underlying
mechanisms oftoxicity.
Introduction
The conventional chronic or long-term animal
toxicity study is a key feature in the assessment of
the safety of chemicals. One may distinguish be-
tween its use for the predictive evaluation of new
compounds and its incorporation in a scheme de-
signed to help lessen or clarify a recognized hazard.
It is required that these studies be carried out in two
species, a rodent and a nonrodent. Animal studies
are essentially comparative, in that the spontaneous
and induced pathological manifestations are com-
pared in control and test animals, respectively. It is
essential to determine whether the lesion or finding
is attributable to the test compound and if so,
whether its incidence is dose-related. The most im-
portant interpretative factors are careful observa-
tion of the living animal, assessed by veterinary
clinical techniques, adequate instrumentation, and
detailed pathological investigations.
The techniques which are available for the inves-
tigation of testicular function apply mainly to the
dog. With the dog, several investigations are possi-
ble. The length and breadth of the testes can be
measured through the scrotal sac using calipers; the
formula iTlbI4, where I is length and b breadth, is
used to calculate the cross-sectional area of the
sagittal plane. This simple technique gives a good
indication of the rate of development of the testes.
Semen samples can be obtained from the dog with
comparative ease by using an artificial vagina (1).
The semen collected can be measured and investi-
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gated by standard methods. The mean volume of
the ejaculate ofthe dog is 3.1 ml. The three fractions
of ejaculate cannot be differentiated, particularly
with respect to the first and second fractions. The
volume ofthe first fraction is small-and flows slowly
over the artificial vagina, so that the first two frac-
tions ale invariably mixed. The concentration ofthe
sperm is not a particularly useful measurement, be-
cause the variation in volume of the third fraction
can cause marked dilution of the spermatozoa. The
total sperm count per ejaculate is a more meaning-
ful measurement; it shows considerable monthly
variation and is usually between 89.4 x 106 and
261.8 x 106.
With the rat, one is limited to inspection and pal-
pation of the gonads. If counts of epididymal sper-
matozoa are required, the rat must be killed. The
ductus deferens is then flushed with 1 ml of 0.9%o
sodium chloride, and the caput, corpus, and cauda
of the epididymis are macerated with 2.0, 1.0, and
2.0 ml of0.9% sodium chloride (NaCl) respectively.
The motility of the sperm can be assessed and
counts made by using the hemocytometer counting
chamber.
The subhuman primates used in toxicological
studies are usually young adolescent and sexually
immature animals, which makes investigation of
testicular function a majorproblem.
The biochemical investigations available are in-
appropriate to the measurement of testicular func-
tion. Investigation of seminal fructose levels could,
however, be of interest. It is possible to measure
circulating plasma hormones, notably FSH, LH,
prolactin, and testosterone, but the value of these
investigations in toxicological studies depends on
June 1978 73the establishment of baseline data. In the beagle
dog, plasma testosterone levels are about 600 ng/ml.
In the monkey, plasma testosterone levels should
be critically reviewed, as considerable seasonal
variations have been demonstrated in this species
(2).
Macroscopic postmortem examination rarely re-
veals any significant pathological changes. Organ
weight analysis is an extremely useful parameter. In
the rat, all organs grow more slowly than the body,
except for the testes and prostate. The testes grow
at the same rate as the body, while the prostate
develops fasters. With increasing age, there is a de-
crease in the gonad weights. In the dog, a linear
positive correlation is found for all organs except
the thymus (3). With the exception ofthe testes and
heart, the organs show negative allometric growth.
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However, positive allometric growth is observed
for the testes within the age range 7-180 days. The
testes of the monkey show a marked increase in
weight, beginning at about three years of age, after
the adolescent growth spurt, and continuing until
five years ofage.
Histopathological examination of tissues is of
crucial importance. Zbinden (4) includes testes and
epididymis in his list of first priority tissues and
organs to be examined. The interpretation of his-
topathological findings must be made with reference
to the recognized common pathology for the species
employed, the changes predictable by virtue of the
pharmacological action of the compound, and man-
ifestation ofnovel and unpredicted response.
In the rat, age change can be detected in the
testes of rats living to two years of age; about 20%
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bilateral atrophy; 8% show atrophy with periarteri-
tic change in the spermatic artery; and in approxi-
mately 2% of animals one can expect to find inter-
stitial cell hyperplasia (Fig. 1). Testicular toxicity in
the rat usually shows as an arrest or impairment of
spermatogenesis, usually accompanied by some at-
rophic change in the prostate or seminal vesicles.
Usually, neither the Sertoli nor the Leydig cells are
involved. Chemically induced testicular atrophy is
illustrated in Figure 2. The findings are consistent
with those reported by Ribelin (5). It is frequently
suggested that reduction in food intake, together
with suppression of body weight gain is of impor-
tance in testicular atrophy. However, in my experi-
ence, these factors are ofminimal importance in the
aetiology of testicular atrophy in the rat: body-
weight gain can be suppressed by up to 45% for 78
weeks without significantly affecting the incidence
of testicular atrophy. Rather unusual manifestations
of testicular toxicity in the rat are the spermatic
granulomata, which appear as soft yellow bilateral
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FIGURE 2. Testicularatrophy, drug-induced, rat. x 125.
June 1978 75bulges within the tunica of the cauda epididymis
Fig. 3). The presence of myeloid bodies in the
-pididymal tissues is another unusual manifestation
f toxicity in the rat (Fig. 4). These bodies are




somes in which the membranous elements are in-
adequately digested. Drug-induced inclusion bodies
in the epididymis could be detrimental to proper
sperm maturation and storage.
Toxicological studies in the dog usually lastforup
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76to two years, at whichtime the testicles do not show
any age-induced changes. In dogs reaching eight
years or more, 11% of animals are found to have
tumorcells, interstitial cell adenomas, orSertoli cell
tumors in the testes. A further 9o of animals show
varying degrees of hyperplasia of the interstitial
cells. The histopathological picture oftoxic change
is one of arrest at varying stages of sper-
matogenesis, accompanied by some changes in the
prostate.
With subhuman primates, we have seen only one
compound which affected the testes, and this in-
duced adegree oftesticular atrophy.
It is desirable that an attempt should be made to
quantitate testicular changes in toxicological
studies. This could be achieved by the classification
of the tubules according to the stages of sper-
mateleosis, with enumeration of the germ cells
present. The diameter of the tubules could be mea-
sured. The ratio ofgerm cells to Sertoli cells might
prove to be auseful index oftesticulartoxicity.
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Toxicity
The testes are not common target organs for tox-
icity. Gomes (6) has reviewed chemical agents af-
fecting male fertility. Compounds affecting the
testes may have direct toxicity, by acting on a par-
ticular stage of spermatogenesis or on the accessory
sex glands, or an indirect effect, by acting on the
interstitial cells or on the adenohypophysis. It is
possible to classify compounds by their mode of
action on the testes.
Steroid Hormones
Inhibition of spermatogenesis by steroid com-
pounds is probably caused by direct action on
spermatogenesis and also by action on those cells in
the endocrine glands which secrete the hormones
essential to normal development. This group of
compounds includes estrogens and progestagens,
compounds used for regulating fertility such as
methallibure and clomiphene, and testosterone.
High dosage levels of methyl testosterone (10 mg/
kg-day and above) suppress spermatogenesis in the
rat, but methyl testosterone has no effect on sper-
matogenesis in the dog when administered at levels
up to 6 mg/kg-day (7).
Neuroleptics
Neuroleptics produce a variety of endocrine and
metabolic effects. Reserpine affects testicular ac-
tivity in the rat. Interstitial tissue atrophy and also
atrophy of the prostate and seminal vesicles occur.
The phenothiazines and the butyrophenones induce
endocrine effects in the female rat, but do not affect
the testes in the male (8). In the dog, phenothiazines
cause low testicle weights, particularly at high dos-
age levels, but no morphological change is induced.
The benzamide derivatives tend to induce changes
in male and female dogs and rodents. The endocrine
effects of these neuroleptics are probably attributa-
ble to effects on the hypothalamic nuclei.
Alkylating Agents
Alkylating agents act on dividing or developing
cells by affecting DNA synthesis. The aziridines,
procarbazine and busulphan, are examples of such
compounds, most of which exert their effect on the
spermatogonia.
Metals
Cadmium is a metal known to affect sper-
matogenesis in several species; it is suggested that
the action is on DNA synthesis.
Compounds Lowering Blood Pressure
Adrenergic neurone-blocking agents, particu-
larly the guanethidine derivatives (9) and other
compounds that reduce hypertension or cause
vasodilation can induce spermatocele granuloma in
rodents. The granulomata are due to leakage of
sperm into the interstitial tissue, following rupture
of the vas deferens at the origin of its straight por-
tion. Rupture is attributable to interference with
seminal emission from the caudaepididymis.
Compounds Inducing Phospholipidosis
Anorectics, hypocholesterolemic agents, and
antihistamines can induce cytoplasmic vacuoles
filled with multicentric myeloid bodies in the
epididymal epithelium.
Cyclohexylamine
Cyclohexylamine is a metabolite ofthe cyclamate
sweeteners and has been shown by Gaunt et al. (10)
to induce suppression ofspermatogenesis in the rat.
Other Compounds
A variety of compounds are cited by Newburgh
(11) as affecting spermatogenesis; these include
phenacetin in rats, hexachlorophene in rats,
fluoroacetamide in rats, Dieldrin in mice, and DDT
in rats. To this list could be added analgesics, an-
titussives, chlorhydrins, vinca alkaloids, and many
others.
Fertility Studies
If the results of a toxicological study indicate a
possible effect on male fertility, the reproductive
function can be studied by a variety oftechniques.
The sensitivity of germinal cells to the harmful
agents increases as differentiation proceeds to the
spermatid stage. Spermatids are sensitive to
mutagenic effects, spermatozoa are somewhat less
sensitive, and spermatogonia are the least sensitive.
Some compounds, particularly the alkylating
agents, produce their effect in the divisional stages,
and the spermatogonia are more sensitive than the
spermatocytes.
The effects of agents affecting spermatogenesis
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are apparent after varying periods, depending on
the type of cells affected (Table 1). If epididymal
sperm are damaged, the semen is affected soon after
the administration ofthe toxic compound, but ifthe
effect is on the spermatogonia, the damaged cells
will not be apparent for several weeks after the
-damage has been done.
Antifertility compounds are tested mainly by
mating untreated female animals with treated males.
The type of damage produced is related to the
change in sperm quality. Death of cells causes a
decrease in the number of sperm. Abnormal sper-
matogenesis may lead to morphological defects, and
damage to the genetic apparatus, which could result
in embryonic death orteratogenicity.
The most useful study is a fertility study in the
rat. The compound under investigation is adminis-
tered by the route most applicable to human expo-
sure at three dosage levels. The male rats only are
treated for 63 days prior to mating and during the
20-day mating period. The high dosage level should
be selected as the one whichjust causes, or fails to
cause, the minimal adverse reaction in the parent
animals. The low dosage should show some re-
lationship to the likely human exposure, whilst the
intermediate dosage should be logarithmically be-
tween the high and low dosage levels. Twelve
treated males and 24 untreated females are required
for each group. If the compound is given by in-
tragastric intubation, a standard dosage volume of 1
ml/100 g body weight is preferred. The control ani-
mals are dosed with the vehicle. Treatment of the
males commences when the animals are 42 days of
age and is continued through the 63 days prior to
mating and during the 20-day mating period. During
this predosing period, clinical signs are noted, and
the body weight is recorded. At mating, one male is
caged with two untreated females. Vaginal smears
are taken daily, and the day when sperm are present
is considered to be day 0 ofgestation. On day 20 of
gestation, ten females per group are sacrificed for
examination of the ovaries, uterus and contained
fetuses. The number of viable young, early and late
resorptions, implantations and corpora lutea are
counted for each female; pre- and post-implantation
losses are subsequently calculated. Each litter is
weighed and the mean pup weight determined. All
fetuses are examined for various external abnor-
malities. Although not routinely processed further,
one half of each litter is preserved in Bouin's solu-
tion and the other halfpreserved in alcohol, against
the contingency ofserial visceral sectioning (Wilson
technique) or clearing and staining of the skeleton
being indicated. The remaining 14 females are al-
lowed to give birth and rear young for 21 days. The
length of gestation is recorded, effects on parturi-
tion and subsequent lactation become apparent, the
number of dead and live young, percentage litter
loss, abnormal young, litter and mean pup weights
are determined for each litter at birth, and sub-
sequently on days 4, 12 and 21 post-partum. Both
dam and litter are sacrificed on day 21 post-partum
and subjected to gross autopsy. The results ofthese
studies are statistically analyzed on a litter basis.
The type of study obviously can be modified by
altering the dosing period or by investigating rever-
sibility of drug effect. The period of administration
of the compound to the male may give rise to con-
siderable practical problems, such as those involved
in continual long-term intravenous injection. Also
of importance is the fact that a rat can develop de-
toxification mechanisms with remarkable rapidity
by enzyme induction and male rats dosed for this
nine-week period might be so affected.
If a mutagenic effect is suspected, a dominant
lethal assay can be made. The dominant lethal assay
should be complemented by teratogenicity studies
and multigeneration or other mutagenic assays. The
usual protocol is to use groups of 20 males, treated
with three dosage levels of the compound, com-
pared with a control group. The compound is usu-
ally administered on five consecutive days by the
intended human route. Two days after the fifth
dose, the test males are paired for one week on a
one-to-one basis with mature untreated females.
Subsequently, new batches ofuntreated females are
caged with the test males during the second, third
and fourth weeks. Further batches of females can
be mated ifpremeiotic stages ofdevelopment are to
be covered. Fourteen days after sperm have been
discovered in the vagina, the females are killed and
examined for corpora lutea, implantation sites, via-
ble embryos and early and late embryonic deaths.
The pre- and post-implantation losses are calculated
and analyzed.
A variety of other tests have been devised, such
as tests to study the fertility and general reproduc-
June 1978 79tive performance, but in these studies the males are
given a pretreatment period of 63 days, while
females are treated for 14 days. The multigeneration
studies are carried out in males and females, each
given the compound under test for 60 days prior to
mating, the treatment being continued throughout
the study for all generations. These studies are ex-
tremely useful in the assessment of male fertility,
but make the separation of male and female effects
very difficult.
Conclusion
The testis is an organ which has received scant
attention from the toxicologist. Techniques are
available to investigate pathological, endocrinologi-
cal, and biochemical changes, and testicular func-
tion can be investigated by a variety of mating
studies. These studies would not only define mor-
phological and biochemical changes, but also the
mechanisms of their induction. Research into the
basic problems of testicular toxicity would be
rapidly rewarded.
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